Antibiotics: Unapproved uses or indications

Clinics in Dermatology

Volumn 18, Issue 1, 2000, Pages 11-16

  Sadick, Neil S ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; DEMECLOCYCLINE; DOXYCYCLINE FOSFATEX; MINOCYCLINE; OXYTETRACYCLINE; PENICILLIN DERIVATIVE; RIFAMYCIN; TETRACYCLINE;

ANTIBIOTIC THERAPY; DERMATITIS; DIABETES INSIPIDUS; DRUG INDICATION; ESOPHAGITIS; HUMAN; PHOTOSENSITIVITY DISORDER; PRIORITY JOURNAL; REVIEW; SKIN INFECTION;

ANTI-BACTERIAL AGENTS; DERMATOLOGIC AGENTS; DRUG APPROVAL; DRUG UTILIZATION; HUMANS; PENICILLINS; RIFAMYCINS; SKIN DISEASES; TETRACYCLINES; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 0033984704     PISSN: 0738081X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0738-081X(99)00091-7     Document Type: Review

References (76)

1. Epstein M.E., Amdio-Groton M., Sadick N.S. Antimicrobial antibiotics for the dermatologist I β-lactam antibiotics and related compounds. J Am Acad Dermatol. 37:1997;149-165.
2. Hoigen R., Keller H., Suntag R., et al. Miscellaneous antibiotics. Dukes M.N. Meyler's side effects of drugs. 12th ed. 1992;637-642 Elsevier, Amsterdam.
3. Kapusnik-Uiver J., Sande M.A., Chambers H.F. Antimicrobial agents. Hardman J.G., Limbird L.E., Malinoff P.B., et al. Goodman and Gillman The pharmacological basis of therapeutics . 9th ed. 1996;1124-1130 McGraw-Hill, New York.
4. Doxycycline. In: Reynolds JEF, Parfitt K, editors. Martindale: The extrapharmacopoeia. 30th ed. London: Pharmaceutical Press, 1993:182-3.
5. Tetracycline. In: Reynolds JEF, Parfitt K, editors. Martindale: The extrapharmacopoeia. 30th ed. London: Pharmaceutical Press, 1993:212-6.
6. Tetracycline. In: Reynolds JEF, Parfitt K, editors. The extrapharmacopoeia. 30th ed. London: Pharmaceutical Press, 1993:221-9.
7. Amichal B., Grunwald M.H. Tetracyclines and their uses in dermatology. Dermatol Treat. 9:1998;221-229.
8. Humbert P., Treffel P., Chapuis J.F. The tetracyclines in dermatology. J Am Acad Dermatol. 25:1991;691-697.
9. Greenwald R.A., Golub L.M., Lavietes B., et al. Tetracyclines inhibit human synovial collagenase in vivo and in vitro. J Rheumatol. 14:1987;28-32.
10. Thong Y.H., Freeante A. Inhibition of mitogen-mauled human lymphocyte proliferative responses by tetracycline analogues. Clin Exp Immunol. 35:1979;443-446.
11. Majeski J.A., Wesley A.J. Evaluation of tetracycline in the neutrophil chemotactic response. J Las Clin Med. 90:1977;259-265.
12. Alexander J.W. Antibiotic agents and the immune mechanisms of defenses. Bull N Y Acad Med. 51:1975;1039-1045.
13. Elewski B.E., Lamb B.A.J., Mitchell Sam W., et al. In vivo suppression of neutrophil chemotaxis by systemically and topically administered tetracycline. J Am Acad Dermatol. 8:1993;807-812.
14. Freinkel R.K., Strauss J.S., Yip S.Y., et al. Effect of tetracycline on the composition of sebum in acne vulgaris. N Engl J Med. 373:1965;850-854.
15. Cunliffe W.S., Faster R.A., Greenwood N.S., et al. Tetracyclines and acne vulgaris A clinical and laboratory investigation . BMJ. 4:1973;332-335.
16. Harrison P.U. A combination of doxycycline and minocycline in the treatment of acne vulgaris. Clin Exp Dermatol. 13:1988;242-244.
17. Gaspar ZS, Walkden V, Wajnnarowska F. Minocycline is a useful adjuvant therapy for pemphigus. 4th Congress of the European Academy of Dermatology and Venerology (abstr 0112). Brussels, 1995.
18. Chaffins M.L., Collison D., Fluenson D.P. Treatment of pemphigus and linear IgA dermatoses with nicotinamide and tetracycline A review of 13 cases . J Am Acad Dermatol. 28:1993;998-1000.
19. Sawoz T., Kitazana K., Danno K., et al. Pemphigus vegetans with oesophageal involvement Successful treatment with minocycline and nicotinamide . Br J Dermatol. 132:1995;668-670.
20. Shaumburg-Lever G., Lever W.F. Familial benign pemphigus. Champion R.H., Burton J.J., Ebling F.J.G. Textbook of dermatology. 5th ed. 1992;642-645 Blackwell Scientific, Oxford.
21. Thornfeldt C.R., Menkes A.W. Bullus pemphigoid controlled by tetracycline and nicotinamide A preliminary report . J Am Acad Dermatol. 165:1987;305-310.
22. Kolbach D.N., Remme J.J., Bos W.H., et al. Bullus pemphigoid successfully controlled by tetracycline and nicotinamide. Br J Dermatol. 133:1995;88-90.
23. Peoples D., Fivenson D.P. Linear IgA bullus dermatosis Successful treatment with tetracycline and nicotinamide . J Am Acad Dermatol. 26:1992;48-49.
24. Timmer C, Jonkman MF, Vander Meer JB. Topical tetracycline in a patient with mucus membrane pemphigoid. 4th Congress of the European Academy of Dermatology and Venerology (abstr C9). Brussels, 1995.
25. Ronbeck B.A., Lind P.O., Thrane P.S. Desquamative gingivitis Preliminary observations with tetracycline treatment . Oral Surg Oral Med Oral Pathol. 69:1990;694-697.
26. Reynolds N.J., Peachy R.D.G. Response of atypical bullous pyoderma gangrenosum to oral minocycline hydrochloride and to pical steroids. Acta Derm Venerol. 70:1990;538-539.
27. Lynch W.B., Borgderfeld W.F. Pyoderma gangrenosum response to minocycline hydrochloride. Cutis. 22:1978;535-537.
28. Berth-Jones J., Tan S.U., Graham-Brown R.A.C., et al. The successful use of minocycline in pyoderma gangrenosum A report of seven cases and review of the literature . J Dermatol Treat. 1:1989;23-25.
29. Amichai B., Lazarov A., Halevy S. Sweet's syndrome and chlamydial infection. Aust J Dermatol. 34:1993;31-33.
30. Recurrent aphthous stomatitis. In: Arnold HL, Udom RB, James WD, editors. Andrews diseases of the skin. 8th ed. Philadelphia: W.B. Saunders, 1990:938-9.
31. Shelly WB, Griffith RF. Pityriasis lichenoides et varioleformis acuta. A report of a case controlled by high dosage of tetracycline. Arch Dermatol 1969;100:598-597.
32. Piamphongsant T. Tetracycline for the treatment of pityriasis lichenoides. Br J Dermatol. 91:1974;319-322.
33. Humbert P., Favire B., Gibey R., et al. Use of anticollagenase properties of doxycycline in the treatment of alpha 1-anti-trypsin deficiency panniculitis. Acta Derm Venereol. 71:1991;189-194.
34. Czamucki N, Tappeiner G, Wolff K. Lupus erythematosus panniculitis. Wien Clin Wochenschr 1979;830-4.
35. Chan H.L. Panniculitis (Rothman-Makai) with good response to tetracycline. Br J Dermatol. 92:1975;351-354.
36. Thomen K., Osterby P. Pustulosis palmaris et plantaris. Br J Dermatol. 89:1973;293-296.
37. Aso M., Miyamoto T., Morimura T., Shimao S. Prurigo pigmentosa successfully treated with minocycline. Br J Dermatol. 120:1989;705-708.
38. Schepis C., Siragusa M., Palazzo R., Ussia A.F., Cavallari V. Prurigo pigmentosa treated with minocycline. Br J Dermatol. 135:1996;158-159.
39. Humbert P., Renaud A., Laurent R., Agache P. Tetracyclines for dystrophic epidermolysis bullosa. Lancet. 1:1989;277-280.
40. White J.E. Minocycline for dystrophic epidermolysis bullosa. Lancet. 1:1989;966-969.
41. Takamori K., Natio K., Taneda A., et al. Increased neutral and collagenase activity in recessive dystrophic epidermolysis bullosa. Br J Dermatol. 108:1983;687-694.
42. McDonagh A.G.J.K., Gaw K., Sodger D.J., et al. White sponge nevus successfully treated with topical tetracycline. Clin Exp Dermatol. 15:1990;152-153.
43. Thomsen K. Mycoses fungoides responding to tetracycline. Br J Dermatol. 105:1981;483-484.
44. Shelly W.B. Dimethyl chlortetracycline and griseofulvin as a specific treatment for mycosis fungoides. Br J Dermatol. 104:1981;477-480.
45. Angell-Besson C., Koeppel M.C., Jacquet P., et al. Confluent and reticulated papillomatosis (Gougert-Carteaud) treated with tetracyclines. Int J Dermatol. 34:1995;567-569.
46. Montemarano A.D., Hengge M., Sau P., et al. Confluent and reticulated papillomatosis response to minocycline. J Am Acad Dermatol. 34:1996;253-256.
47. Halpern SM, Memon AA, Rhodes LEE, et al. Topical and systemic tetracyclines inhibit nickel-induced contact hypersensitivity. The 78th Annual Meeting of the British Association of Dermatologists (abstr). Brighton, 1998.
48. Shelly W.B. Essential progressive telangiectasia Successful treatment with tetracycline . JAMA. 216:1971;1343-1344.
49. Wallach H.W. Intrapleural tetracycline for malignant pleural effusions. Chest. 68:1975;510-512.
50. Shepherd F.A., Morgan C., Evans W.K., et al. Medical management of malignant pericardial effusion by tetracycline sclerosis. Am J Cardiol. 60:1987;1161-1166.
51. Shaw D.W.W., Bertino R.E., Mulholland M., et al. Use of tetracycline for sclerosis of a biliary cutaneous fistula. AJR Am J Roentgenol. 153:1989;65-66.
52. Ding X. Sclerotherapy with tetracycline for hydrocoele of the tunica vaginales testis. Br J Urol. 4:1989;322-326.
53. Treece G.L., Georgitis W.J., Hofeldt F.D. Resolution of recurrent thyroid cysts with tetracycline instillation. Arch Intern Med. 143:1983;2285-2287.
54. Tanigaki T., Kanada R. The care of eosinophilic pustular folliculitis with effective minocycline therapy. Rivsho Derm. 26:1984;1129-1133.
55. Muto M., Nishimura M., Koga T. Follicular mucinosis responding well to oral minocycline and indothecacine administration. Nishinihon J Dermatol. 50:1988;428-431.
56. Aberev E., Neuman R., Stanek G. Is localized scleroderma a Borrelia infection? Lancet. 26:1985;278-280.
57. Theusan G., Rees D.H.E., Stina G. Borrelia burgdorferi and localized scleroderma. Clin Dermatol. 12:1994;475-479.
58. Asbrink E. Acrodermatitis chronica atrophicans. Clin Dermatol. 11:1993;369-375.
59. Shelly W., Shelly E.D. Advanced dermatologic therapy. 1987;94-95 W.B. Saunders, Philadelphia.
60. Bale P.M., Lochhead A., Martin H.C.D., et al. Balanitis xerotica obliterans in children. Pediatr Pathol. 7:1987;617-627.
61. Arndt KA, Dwer JS, Olbricht SM, editors. Lasers in cutaneous and aesthetic surgery. Philadelphia: Lippincott-Raven, 1997:243-6.
62. Shelly W.B., Shelly D., Grunenwald M.A., et al. Long-term antibiotic therapy for balanitis xerotica obliterans. J Am Acad Dermatol. 40:1999;69-72.
63. Laymon C.W., Freeman C. Relationship of balanitis xerotica obliterans to lichen sclerosis et atrophicus. Arch Dermatol. 49:1994;57-59.
64. Uefflt J.J., David B.M., Grinwood R.D. Lichen sclerosis. J Am Acad Dermatol. 32:1995;393-416.
65. Heuser W.E.J., Remington J.S. Effect of antimicrobial agents on the immune response. Ristuccia Am Cunha B.A. Antimicrobial therapy. 1984;55-79 Raven Press, New York.
66. Thyresson N. The penicillin treatment of acrodermatitis atrophicans chronica (Herxheimer). Acta Derm Venereol (Stockh). 29:1949;572-621.
67. Asbrink E., Hovmark A., Hederstedt B. The spirochetal etiology of acrodermatitis chronica atrophicans Herxheimer. Acta Derm Venereol (Stockh). 64:1984;506-512.
68. Meis J.F., Koopman R., Van Bergen B., et al. No evidence for a relation between Borrelia burgdorferi infection and old lesions of localized scleroderma (morphea). Arch Dermatol. 129:1993;386-387.
69. Goltz R.W., Burgdorf W.H.C. Anetoderma (macular atrophy) and acrodermatitis chronica atrophicans. Fitzpatrick T.B., Eisen A.Z., Wolff K., et al. Dermatologic general medicine. 4th ed. 1997;696-700 McGraw-Hill, New York.
70. Venenae P.Y., Winkelman W.R.H., Moore B.A. Anetoderma Clinical findings associations and long-term follow-up evaluation . Arch Dermatol. 120:1984;1032-1039.
71. Tsankov N., Kasteva M. Rifampin therapy in several forms of psoriasis. J Dermatol Treat. 3:1992;69-71.
72. Johnson T.M., Dvic M., Rapini R.P. AIDS exacerbation of psoriasis (letter). N Engl J Med. 313:1983;1415.
73. Green M.S., Pyrstowsky J.H., Cohen S.R., et al. Infectious complications of erythroderma psoriasis. J Am Acad Dermatol. 34:1996;911-914.
74. Leuna D.Y.M., Travers J.B., Giorno R., et al. Evidence for streptococcal superantigen-driven process in acute guttate psoriasis. J Clin Invest. 96:1995;2106-2112.
75. Vincent F., Ross J.B., Dalton M., et al. A therapeutic trial of the use of penicillin V or erythromycin with or without rifampin in treatment of psoriasis. J Am Acad Dermatol. 26:1992;458-461.
76. Bachs L., Pares A., Elena M., et al. Effects of long-term rifampin administration in primary biliary cirrhosis. Gastroenterology. 102:1992;2077-2080.